The eyedrops Larkin and his team developed contain a synthetic peptide that acts to block the pathways which cause the ...
Research in horses may eventually lead to a treatment for people who develop blindness as a result of the autoimmune disease ...
13 A further example is that CD6-ADC has demonstrated promise in treating two preclinical models of autoimmune uveitis and a humanized model of GVHD, indicating that CD6-ADC may be developed even ...
Acelyrin earlier this month agreed to an all-stock merger with fellow immune player Alumis, with their combined cash tiding ...
A multicenter study led by researchers from the State Key Laboratory of Ophthalmology in China has characterized a distinct ...
‘HLA-A29 uveitis’ more adequately reflects the current, updated clinical context. This name change would have the same implications as HLA-B27 uveitis because both terms reference diseases for which ...
Join MIMS now and pay nothing for the first 30 days Join GPOnline now and pay nothing for the first 30 days ...
CNET’s expert staff reviews and rates dozens of new products and services each month, building on more than a quarter century of expertise.